Early research (Phase 1)Study completedNCT06693765
What this trial is testing
Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
Who this might be right for
Renal ImpairmentEnd-stage Kidney DiseaseHealthy Participants
AstraZeneca 41